These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 25384535)

  • 61. Keratin Retraction and Desmoglein3 Internalization Independently Contribute to Autoantibody-Induced Cell Dissociation in Pemphigus Vulgaris.
    Schlögl E; Radeva MY; Vielmuth F; Schinner C; Waschke J; Spindler V
    Front Immunol; 2018; 9():858. PubMed ID: 29922278
    [No Abstract]   [Full Text] [Related]  

  • 62. A comparison of anti-desmoglein antibodies and indirect immunofluorescence in the serodiagnosis of pemphigus vulgaris.
    Zagorodniuk I; Weltfriend S; Shtruminger L; Sprecher E; Kogan O; Pollack S; Bergman R
    Int J Dermatol; 2005 Jul; 44(7):541-4. PubMed ID: 15985020
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Low pathogenicity of anti-desmoglein 3 immunoglobulin G autoantibodies contributes to the atypical clinical phenotypes in pemphigus.
    Saleh MA; Hashimoto R; Kase Y; Amagai M; Yamagami J
    J Dermatol; 2015 Jul; 42(7):685-9. PubMed ID: 25914046
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pemphigus Vulgaris and Foliaceus IgG Autoantibodies Directly Block Heterophilic Transinteraction between Desmoglein and Desmocollin.
    Ishii K; Yoshida K; Stanley JR; Yamagami J; Amagai M; Ishiko A
    J Invest Dermatol; 2020 Oct; 140(10):1919-1926.e7. PubMed ID: 32142800
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The imbalance of Th17 and regulatory T cells in pemphigus patients.
    Xu RC; Zhu HQ; Li WP; Zhao XQ; Yuan HJ; Zheng J; Pan M
    Eur J Dermatol; 2013; 23(6):795-802. PubMed ID: 24192290
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Detection of antibodies against the non-calcium-dependent epitopes of desmoglein 3 in pemphigus vulgaris and their pathogenic significance.
    Kamiya K; Aoyama Y; Shirafuji Y; Hamada T; Morizane S; Fujii K; Hisata K; Iwatsuki K
    Br J Dermatol; 2012 Aug; 167(2):252-61. PubMed ID: 22404487
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of commercially available ELISA assays as a tool for monitoring and managing pemphigus patients: a prospective study.
    Bracke S; Speeckaert R; Van Geel N; De Bacquer D; Lambert J
    Eur J Dermatol; 2013; 23(1):33-9. PubMed ID: 23302186
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Herpetiform pemphigus without anti-desmoglein 1/3 autoantibodies.
    Nakashima H; Fujimoto M; Watanabe R; Ishiura N; Yamamoto AI; Hashimoto T; Tamaki K
    J Dermatol; 2010 Mar; 37(3):264-8. PubMed ID: 20507392
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].
    España Alonso A; Panizo C; Fernández S; Marquina M; Pretel M; Aguado L; Sánchez-Ibarrola A
    Actas Dermosifiliogr; 2009 Mar; 100(2):113-20. PubMed ID: 19445875
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Spectrum of autoantibodies other than anti-desmoglein in pemphigus patients.
    Mejri K; Abida O; Kallel-Sellami M; Haddouk S; Laadhar L; Zarraa IR; Ben Ayed M; Zitouni M; Mokni M; Lahmar H; Fezaa B; Turki H; Tron F; Masmoudi H; Makni S
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):774-81. PubMed ID: 21029209
    [TBL] [Abstract][Full Text] [Related]  

  • 71. E-cadherin autoantibody profile in patients with pemphigus vulgaris.
    Oliveira ME; Culton DA; Prisayanh P; Qaqish BF; Diaz LA
    Br J Dermatol; 2013 Oct; 169(4):812-8. PubMed ID: 23725016
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The transition of pemphigus vulgaris into pemphigus foliaceus: a reflection of changing desmoglein 1 and 3 autoantibody levels in pemphigus vulgaris.
    Harman KE; Gratian MJ; Shirlaw PJ; Bhogal BS; Challacombe SJ; Black MM
    Br J Dermatol; 2002 Apr; 146(4):684-7. PubMed ID: 11966706
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Analysis of immunological profile, clinical features and response to treatment in pemphigus.
    Bardazzi F; Balestri R; Ismaili A; LA Placa M; Barisani A; Patrizi A
    G Ital Dermatol Venereol; 2017 Dec; 152(6):569-577. PubMed ID: 27352177
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Endemic pemphigus foliaceus in the Peruvian Amazon.
    Ortega-Loayza AG; Ramos W; Gutierrez EL; Jimenez G; Rojas I; Galarza C
    Clin Exp Dermatol; 2013 Aug; 38(6):594-600. PubMed ID: 23692307
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels.
    Harman KE; Seed PT; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
    Br J Dermatol; 2001 Apr; 144(4):775-80. PubMed ID: 11298536
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Anti-Thyroid Peroxidase Reactivity Is Heightened in Pemphigus Vulgaris and Is Driven by Human Leukocyte Antigen Status and the Absence of Desmoglein Reactivity.
    Seiffert-Sinha K; Khan S; Attwood K; Gerlach JA; Sinha AA
    Front Immunol; 2018; 9():625. PubMed ID: 29675021
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multiplexed autoantigen microarrays identify HLA as a key driver of anti-desmoglein and -non-desmoglein reactivities in pemphigus.
    Sajda T; Hazelton J; Patel M; Seiffert-Sinha K; Steinman L; Robinson W; Haab BB; Sinha AA
    Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1859-64. PubMed ID: 26831096
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
    Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
    J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synergy among non-desmoglein antibodies contributes to the immunopathology of desmoglein antibody-negative pemphigus vulgaris.
    Chernyavsky A; Amber KT; Agnoletti AF; Wang C; Grando SA
    J Biol Chem; 2019 Mar; 294(12):4520-4528. PubMed ID: 30692201
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Serum and salivary IgG and IgA antibodies to desmoglein 3 in mucosal pemphigus vulgaris.
    Ali S; Kelly C; Challacombe SJ; Donaldson AN; Bhogal BS; Setterfield JF
    Br J Dermatol; 2016 Jul; 175(1):113-21. PubMed ID: 26799252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.